跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
THIOTEPA FOR INJECTION, BP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
THIOTEPA FOR INJECTION, BP
Authorized
STANDARD
THIOTEPA FOR INJECTION, BP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a47e106672685be6
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
a47e106672685be6
Drug Approval Canada Name
THIOTEPA FOR INJECTION, BP
Product Name
THIOTEPA FOR INJECTION, BP
Status
Marketed
Status Date
2023-06-27
Original Market Date
2023-06-27
Din
02536870
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AC01 THIOTEPA
Atc Name
l 01 ac 01
Aig Number
0107649002
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
THIOTEPA
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a47e106672685be6
Type
Standard
Back to Health Canada Approvals